ZyVersa Therapeutics (NASDAQ:ZVSA – Get Free Report) is expected to be announcing its earnings results before the market ...

The National Kidney Foundation (NKF) is proud to announce that its KidneyCARE (Community Access to Research Equity)™ Study – ...

C3 Glomerulopathy (C3G), Focal Segmental Glomerulosclerosis (FSGS), Polycystic Kidney Disease (PKD), Alport Syndrome, Fabry Disease, and more. By capturing diverse patient experiences, the study ...

Additionally, people with recurrent kidney stones, structural abnormalities, or genetic conditions like polycystic kidney ...

Clinical trials are investigating approaches to correct faulty genes in conditions like polycystic kidney disease and Alport syndrome. Xenotransplantation—using genetically modified animal ...

alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising ...

Additionally, people with recurrent kidney stones, structural abnormalities, or genetic conditions like polycystic kidney disease (PKD) or Alport syndrome should undergo regular kidney function tests.

For millions living with rare diseases, the road to diagnosis and treatment is often filled with uncertainty. It is also similar with patients that are diagnosed with rare kidney disorders as these ...